Analysis of Structural Characteristics and Psychometric Properties of the SarQoL® Questionnaire in Different Languages: A Systematic Review

Martínez-Fernández, María Visitación; Sandoval-Hernández, Irene; Galán-Mercant, Alejandro; Gónzalez-Sánchez, Manuel; Martínez-Cal, Jesús; Molina-Torres, Guadalupe

doi:10.3390/ijerph19084561

Cited by 3 publications

(5 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After carefully assessing the psychometric properties of the translated versions of SarQoL based on the COSMIN guidelines [ 20 , 59 ], the authors concluded that the analysed versions have psychometric properties that can be qualitatively classified between good and excellent. They state that SarQoL is valid for assessing the quality of life in people with sarcopenia in different countries [ 44 ]. The authors however regret the absence of content validity measurement across the different validation analyses.…”

Section: Discussion / Expert Commentarymentioning

confidence: 99%

“…However, this is currently only an assumption based on a small amount of preliminary evidence, and no statistical measure of the sensitivity to change using anchor questions was performed. Second, as highlighted in the systematic review by Martinez-Fernandez [ 44 ], the content validity of SarQoL has rarely been studied so far. Because content validity is a psychometric property recognized by COSMIN, future studies should investigate this property in different populations.…”

Section: Discussion / Expert Commentarymentioning

confidence: 99%

“…Second, as highlighted in the systematic review by Martinez-Fernandez [ 44 ], the content validity of SarQoL has rarely been studied so far. Because content validity is a psychometric property recognized by COSMIN, future studies should investigate this property in different populations.…”

Section: Discussion / Expert Commentarymentioning

confidence: 99%

“…In 2022, an independent systematic literature review was published to analyse the structural characteristics and psychometric properties of SarQoL in different languages [ 44 ]. At that time, the authors were able to include 14 individual studies reporting on the psychometric properties of SarQoL.…”

Section: Psychometric Properties Of Sarqolmentioning

confidence: 99%

See 3 more Smart Citations

Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties

Beaudart,

Reginster,

Amuthavalli Thiyagarajan

et al. 2023

Aging Clin Exp Res

View full text Add to dashboard Cite

Patient perspectives are now widely recognized as a key element in the evaluation of health interventions. Therefore, the provision of specific and validated Patient Reported Outcome Measures that emphasize the lived experience of patients suffering from specific diseases is very important. In the field of sarcopenia, the only validated specific health-related quality of life (HRQoL) instrument available is the Sarcopenia Quality of Life questionnaire (SarQoL). This self-administrated HRQoL questionnaire, developed in 2015, consists of 55 items arranged into 22 questions and has currently been translated into 35 languages. Nineteen validation studies performed on SarQoL have consensually confirmed the capacity of SarQoL to detect difference in HRQoL between older people with and without sarcopenia, its reliability and its validity. Two further observational studies have also indicated its responsiveness to change. A short form SarQoL, including only 14 items has further been developed and validated to reduce the potential burden of administration. Research on the psychometric properties of SarQoL questionnaire is still encouraged as the responsiveness to change of SarQoL has not yet been measured in the context of interventional studies, as limited prospective data currently exist and as there is still not cut-off score to define a low HRQoL. In addition, SarQoL has mainly been used in community-dwelling older individuals with sarcopenia and would benefit to be studied in other types of populations. This review aims to provide to researchers, clinicians, regulators, pharmaceutical industries and other stakeholders a clear summary of comprehensive evidence on the SarQoL questionnaire published up to January 2023Query.

show abstract

Section: Discussion / Expert Commentarymentioning

confidence: 99%

Section: Discussion / Expert Commentarymentioning

confidence: 99%

Section: Discussion / Expert Commentarymentioning

confidence: 99%

Section: Psychometric Properties Of Sarqolmentioning

confidence: 99%

See 2 more Smart Citations

Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties

Beaudart,

Reginster,

Amuthavalli Thiyagarajan

et al. 2023

Aging Clin Exp Res

View full text Add to dashboard Cite

show abstract

“…However, these previous studies used different diagnostic criteria for SO than those recently established by ESPEN/EASO [ 10 ], so it is pertinent to study quality of life in older adults using the new diagnostic criteria for SO as well as the EWGSOP2 criteria [ 2 ]. Moreover, as recommended by Tsekoura et al [ 4 ], such assessments should be undertaken using a specific tool, such as the Sarcopenia and Quality of Life (SarQol) instrument [ 15 ], whose different cross-cultural versions have shown very good structural and psychometric properties in people with sarcopenia [ 16 ].…”

Section: Introductionmentioning

confidence: 99%

Assessing quality of life with SarQol is useful in screening for sarcopenia and sarcopenic obesity in older women

Fonfría-Vivas¹,

Pérez‐Ros²,

Barrachina-Igual³

et al. 2023

Aging Clin Exp Res

View full text Add to dashboard Cite

Background Health-related quality of life (HRQoL) may be impaired in the presence of sarcopenia. Since a specific quality of life questionnaire became available for sarcopenia (SarQol), cutoffs to screen for this condition have been proposed, prompting the need to assess them in different populations. Due to the lack of consensus on diagnostic criteria, the tool has not yet been analyzed in screening for sarcopenic obesity. Aim Our aim is to measure the SarQoL’s metric properties and establish a cutoff in QoL assessments that could be used along the diagnostic pathway for sarcopenia and sarcopenic obesity in community-dwelling older women. Methods This cross-sectional study assessed women aged ≥ 70 years using the SarQol, sarcopenia criteria (EWGSOP2) and sarcopenic obesity criteria (ESPEN/EASO). Cutoffs for the SarQol were defined with a receiver-operating characteristics (ROC) curve, and sensitivity and specificity were analyzed. Results Of the 95 included women (mean age 76.0 years, standard deviation [SD] 5.7), 7.3% (n = 7) were classified as having sarcopenic obesity, 22.1% (n = 21) as having sarcopenia, and 70.5% (n = 67) as not having sarcopenia. The total SarQol score was higher in women without sarcopenia (66.5 SD 16.2) versus those with sarcopenia (56.6 SD 15.6) and sarcopenic obesity (45.1 SD 7.9). A cutoff of ≤ 60 points is proposed for sarcopenia screening (area under the ROC curve [AUC] 0.67; 95% confidence interval [CI] 0.53–0.80; sensitivity 61.9%; specificity 62%), and ≤ 50 points for sarcopenic obesity (AUC 0.85; 95% CI 0.74–0.95; sensitivity 71.4%; specificity 76.9%). Conclusions Quality of life is compromised in women with sarcopenia and especially in those with sarcopenic obesity. The SarQol could be useful in screening for these conditions, providing insight into health-related quality of life in older people with sarcopenia.

show abstract

Contemporary approach to osteosarcopenia

Tomasevic-Todorovic

Ilić

2022

Med pregl

View full text Add to dashboard Cite

Introduction. The elderly are at high risk of developing osteosarcopenia, which is characterized by the coexistence of osteoporosis and sarcopenia. There are many factors that affect the interaction between bones and muscles: genetics, hormones, nervous system, aging, cardiac rhythm, nutrition. Pathophysiology of osteosarcopenia. Risk factors include: age of 50 years and over, sex, Caucasian race, genetic predisposition, short stature, malnutrition, physical inactivity, amenorrhea, late menarche, early menopause, estrogen and androgen deficiency, alcohol consumption, cigarette smoking, calcium deficiency in the diet, use of some drugs. Complications of osteosarcopenia include frequent bone fractures, physical disability, and mortality in the elderly population. Diagnostics. The gold standard is magnetic resonance imaging and computed tomography to assess muscle tissue. Bioelectric impedance analyzes the composition of the body, based on the speed at which electricity moves through tissues. Drug treatment of osteosarcopenia. Modern treatment of osteosarcopenia includes application of bisphosphonates, selective estrogen-receptor modulators, monoclonal antibodies, hormonal therapy, estrogens, and supplementation with calcium preparations and vitamin D. Prevention. Lifestyle changes and non-pharmacological measures are most important for healthy bones and muscles. Physical activity, nutrition rich in calcium and vitamin D, smoking and alcohol consumption are of crucial importance for people of all ages, especially for the elderly. The therapy should be reevaluated at least annually, and the quality of life should be assessed.

show abstract

Analysis of Structural Characteristics and Psychometric Properties of the SarQoL® Questionnaire in Different Languages: A Systematic Review

Cited by 3 publications

References 38 publications

Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties

Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties

Assessing quality of life with SarQol is useful in screening for sarcopenia and sarcopenic obesity in older women

Contemporary approach to osteosarcopenia

Contact Info

Product

Resources

About